- 関
- bioreduction、bioreductively
English Journal
- Characterisation of radicals formed by the triazine 1,4-dioxide hypoxia-activated prodrug, SN30000.
- Anderson RF1, Yadav P, Patel D, Reynisson J, Tipparaju SR, Guise CP, Patterson AV, Denny WA, Maroz A, Shinde SS, Hay MP.
- Organic & biomolecular chemistry.Org Biomol Chem.2014 Jun 7;12(21):3386-92. doi: 10.1039/c4ob00236a. Epub 2014 Apr 16.
- The radical species underlying the activity of the bioreductive anticancer prodrug, SN30000, have been identified by electron paramagnetic resonance and pulse radiolysis techniques. Spin-trapping experiments indicate both an aryl-type radical and an oxidising radical, trapped as a carbon-centred rad
- PMID 24737463
- Hypoxia-regulated gene network in drug resistance and cancer progression.
- Lin SC1, Liao WL, Lee JC, Tsai SJ.
- Experimental biology and medicine (Maywood, N.J.).Exp Biol Med (Maywood).2014 May 8. [Epub ahead of print]
- Hypoxia is a common phenomenon of solid tumors and contributes to aggressive phenotype and treatment failure. Hypoxia-inducible factor (HIF), a versatile transcription factor that regulates more than 5% of total human genes, not only plays important roles in controlling physiological processes, but
- PMID 24812122
- Genotoxicity and cytotoxicity evaluation of oenothein B and its protective effect against mitomycin C-induced mutagenic action.
- Silva CA, Silva CR, Véras JH, Chen-Chen L, Ferri PH, Santos SD.
- Mutation research. Genetic toxicology and environmental mutagenesis.Mutat Res Genet Toxicol Environ Mutagen.2014 Apr 19;767C:8-12. doi: 10.1016/j.mrgentox.2014.04.003. [Epub ahead of print]
- The natural product oenothein B (OeB), a dimeric macrocyclic ellagitannin, has a wide range of biological activities, such as antioxidant, anti-inflammatory, anti-viral, antifungal, and antitumor. However, investigations concerning its genotoxicity have not been carried out. This study assessed the
- PMID 24751336
Japanese Journal
- Pathophysiological Response to Hypoxia — From the Molecular Mechanisms of Malady to Drug Discovery:Drug Discovery for Targeting the Tumor Microenvironment
- Nagasawa Hideko
- Journal of Pharmacological Sciences 115(4), 446-452, 2011
- The tumor microenvironment, characterized by regions of hypoxia, low nutrition, and acidosis due to incomplete blood vessel networks, has been recognized as a major factor that influences not only the …
- NAID 130000663506
- 金属イオン還元細菌 Shewanella algae によるパラジウムの還元・回収
- 玉置 洸司郎,齋藤 範三,荻 崇,野村 俊之,小西 康裕
- 化学工学論文集 36(3), 288-292, 2010-07-20
- 金属イオン還元細菌Shewanella algaeの静止細胞は,ギ酸塩または乳酸塩を電子供与体として用いて,初期液相濃度1–10 mol/m3のPdCl2水溶液からパラジウムを細菌細胞内に還元・回収することができた.とくにギ酸塩を電子供与体に用いた場合には,S. algaeによるPd(II)イオンの還元は迅速に進行し,Pd(II)イオンの最大還元・回収速度は2.14×10?14 g-P …
- NAID 10027040825
Related Links
- Bioreductive agents are drugs that must undergo reduction to form an active cytotoxic species. The existence within solid tumors of regions of hypoxia offers the possibility of using such bioreductive agents to exert tumor-specific ...
Related Pictures
★リンクテーブル★
[★]
- 関
- bioreductive、bioreductively
[★]
- 英
- bioreduction、bioreductive、bioreductively
[★]
- 関
- bioreduction、bioreductive